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In this thesis, we will examine the statistical methods used in survival analysis applied to
interval-censored failure time data. Interval-censored data is not widely used due to the fact that
it is more difficult to work with. However, the same methods commonly used for randomcensoring can be applied to interval-censoring as well. This includes finding the basic quantities,
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CHAPTER 1: INTRODUCTION
Survival analysis is a common practice for analyzing time until an event of interest.
These events can be occurrence of a disease, death, the failure of a mechanical component on a
machine, divorce, etc. The time until such an event of interest is generally referred to as the
failure time. The analysis of the failure time data usually includes the estimation of the survival
function, a comparison of treatments or survival functions, and assessment of covariate effects.
The survival time is commonly referred to as the variable of interest. The survival function is
that which gives the probability that the failure time is greater than a certain time and is of much
importance. Survival analysis is mostly used in medical and engineering studies but can also
appear in other areas such as sociological studies, epidemiological studies, etc.
This analysis is complicated by censoring, a problem unique to failure time data.
Censoring refers to an observation in the study being incomplete; that is, the survival time is
observed only to fall into a certain range instead of being exactly known (Sun, 2006). This is not
to say, however, that censoring is the same as missing data. Censoring still provides some
information about the data, whereas missing data provides no information. There are three
different types of censoring: left, right, and interval. Left censoring occurs when the event has
already occurred before the enrollment into the study. This is a rare encounter. Right censoring,
the most common type of censoring, occurs when the event does not occur before the study ends.
This usually happens due to time constraints or resource limitations. In the case of right-censored
data, the survival times are not observed exactly but are known to be greater than the time at the
end of the study (Sun, 2006). It is possible for the study to end at different times for different
subjects. Right-censored models are commonly referred to as random censorship models. Right-
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and left-censored data are specific types of interval-censored data. Interval censoring occurs
when the exact failure time is unknown but is known to occur in some window of time. The
subjects are not under continuous observation, however; subjects are observed several times
throughout the study. Interval-censored data arises in several ways; for example, an individual
may miss one or more appointments and return with the disease of interest. There are two types
of interval-censored data, Case I and Case II, described below. “Interval-censored failure time
data occur in many areas and most typically in medical or health studies that entail periodic
follow-ups such as clinical trials and longitudinal studies” (Sun, 2006, p. 5). The statistical
methods for right-censored data do not apply to those of interval-censored data. Intervalcensored data is more challenging to compute.
1.1 Case I and Case II
Interval-censored data is classified as either Case I or Case II data. Case I, also known as
current status data, usually refers to what is known about the failure time . The only known
knowledge of

is whether it has occurred before the observation time or not. With current status

data, the exact value of the survival time is not observed at all. In other words, if L = 0 the
observation is left censored and if R = ∞ the observation is right censored. Case I intervalcensored data occur when the event is observed only once and is only concerned with whether
the event is before the observation time or not. This differs from right- or left-censored data
because right- and left-censored data usually have exact values of the survival time.
Case II interval-censored data, also known as general interval-censored data, includes at
least one interval in which both endpoints belong to (0, ∞ ) (Sun, 2006). Thus subjects are usually
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observed more than once in the general case. Case I interval-censored data is a special case of
Case II interval-censored data. This type of data generally arises when the event of interest
cannot be determined or estimated.
1.2 Independence Assumption
For interval-censored data, similar to right-censored data, there is an independence
assumption. It is assumed that the mechanism that generates the censoring is independent about
the event time of interest (Sun, 2006). With respect to the interval I = (L, R] containing the
event time, T, this means that

(

)

P T ≤ t | L = l , R = r , L < T < R = P(T ≤ t | L < T < R ) .

(1.1)

Essentially this says that, except for the fact the T lies between L and R, the interval does not
provide any extra information about T; T is assumed to be independent of L and R.

CHAPTER 2: BASIC QUANTITIES FOR INTERVAL-CENSORED DATA
In this chapter we describe statistical inferences for basic quantities often used in survival
analysis for interval-censored data.
2.1 Nonparametric Estimate of Survival Function
In survival analysis, the first task is usually to estimate the survival function or the
cumulative distribution function (CDF) of the failure time of interest. For right-censored data,
this is done by finding the Kaplan Meier estimate; however, for interval-censored data the
Kaplan Meier estimate cannot be computed. Instead, nonparametric maximum likelihood
estimate (NPMLE) is used. Let

be the survival time and ( ) = P (T ≤ t) (the CDF of the

survival times) and the survival function S (t) = 1 − F(t). If we estimate one, it is easy to
estimate the other, we will estimate the survival function since it is more widely used.

Sun (2006) proposes the following method for finding the NPMLEs for both Case I and
Case II interval-censored data. For Case I interval-censored data, current status data, let
denote survival times with survival function ( ) where = 1, … , , where the

independent. We assume the observed data has the form: ( , δ ) = 1, … ,
observation time for subject independent of

and δ = (

’s

subjects are

, where

is the

). The resulting likelihood

≤

function is:

/

( ) =

"
#$%

[ (&# )]%(δ# [% − (&# )]δ# .

Let *+, -,$. denote the unique order elements of 0,

; = 1, … ,

. Define

(2.1)

5
4

2, = 3 δ
$5

= +, ,

(2.2)

= +,

(2.3)

where 2, is the number of subjects who are observed at time +, and are found to have failed. Let
,

4

=3
$5

be the number of subjects who are observed at +, , 6 = 1, … , 7. Given these variables, we can
rewrite our likelihood function as:
( ) =

89

/
,$5

[ (+, )]4:(;: [1 − (+, )];: .

(2.4)

For current status data only, a closed form of the NPMLE can be found. Specifically, we
can show that the NPMLE is equal to the isotonic regression of < 4> , … , 4? @ with
=

weights

and

5, … ,

, denotes

/

5

=

?

where
A, = 3

єC:

≤

,

,

(2.5)

the number of elements in D, where D, denotes the set of subjects who are

observed at time , ,6 = 1, … , 7. Using the max-min formula for isotonic regression, the NPMLE
is
E

,

= 1 − 7FGHI, 7

J≥,

J

A,
N.
J
∑M$H ,
M$H

K3

(2.6)

For Case II interval-censored data, we consider a survival study that involves n
independent subjects and yields only interval-censored data. Interval-censored data is usually
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represented by

4
$5

where

= (8 , O ] is the interval that contains the unobserved survival

time associated to the ith subject and n is the sample size. If Li = 0, we have a left-censored
observation, and if Ri =∞, we have a right-censored observation. Let +,
ordered survival times of {0, 8
+, є(8 , O ] and R, =

4
$5 ,

O

4
$5 , ∞}

/
,$. denote

the unique

i.e. 0 = +. < +5 < … <+/ <+/P5 = ∞, Q , =

+,(5 − (+, ). In other words, +, is an ordered list of all of the survival

times in a data set, starting with 0 indicating a left-censored observation and ending with infinity,
indicating a right-censored observation. There are a total of 7 + 1 data points in a given dataset.
R, is defined as the difference in two consecutive survival functions. For example, suppose we
are given an interval-censored dataset:
Left

Right

0

1

1

3

1

3

2

5

5

∞
5.

*+, -,$. = 0, 1, 1, 1, 2, 3, 3, 5 5, ∞ . Q55 = (+5 X[0,1]) = 1 since +5 = 1. R5 = (+. ) − (+5 ).

Under the independence assumption, the likelihood function of p = (R5 , … , R/P5 )Y is
proportional to
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89 (Z) =

4
$5

(8 ) − (O ) =

4

/

3 Q , R, .

$5 ,$5

(2.7)

We want the likelihood function of Z because then our likelihood function is only dependent on
through the values of +, . It is hard to find the nonparametric maximum likelihood estimator

(NPMLE) of S because it becomes a problem to maximize 89 (Z) with respect to p subject to
∑/
,$5 R, = 1 and R, ≥ 0 (6 = 1, … , 7). The likelihood depends on S only though the

values

(+, )

/
,$5 .

The NPMLE can be determined only over the observed intervals (+,(5, +, ] and

the behavior of S in these intervals is unknown. The estimate of the survival function is typically
taken as a right continuous step function, i.e. E ( ) = E (+,(5 ) when +,(5 ≤ + ≤ +, .

Since there is no closed form of the NPMLE for Case II interval-censored data, there are
several proposed ways to maximize the likelihood function (for Case II interval-censored data),
some of which include the self-consistency algorithm given by Turnbull (1976), ICM algorithm
given by Groeneboom and Wellner (1992), and the EM-ICM algorithm given by Wellner and
Zhan (1997). Below we describe three ways.
(I) The first and simplest one is self-consistency algorithm. Turnbull proposed the
algorithm to proceed as follows (Tao, 2010):
Step 1: Compute the probability of an event occurring,
R, =

,(5

− ( , ),

6 = 1, … , 7.

Step 2: Estimate the number of events which occurred at time

,

by

(2.8)

8
4

Q , R,
/
∑
Q [ R[
$5 [$5

A, = 3

, 6 = 1, … , 7.

Step 3: Compute the estimated number at risk time

,

/

\, = 3 A[ .
[$,

(2.9)

by

(2.10)

Step 4: Compute S as the updated “product limit estimator” by applying the Nelson-Aalen
estimator formula, that is:
]E = 3

,:_` I_

A,
.
\,

(2.11)

Continue these steps until S converges. This will be the Turnbull estimator (Tao, 2010). SAS and
R typically use the Turnbull estimator. (II) Second, a more general approach of the selfconsistency algorithm is used to treat the interval-censored data as incomplete data and apply the
EM algorithm (Sun, 2006). Here we can maximize 89 (Z) using the iterative convex minorant

(ICM) which will converge faster than the self-consistency algorithm. This has been seen as an
optimized version of the pool-adjacent violator algorithm. (III) Third, use the EM-ICM
algorithm. This is a combination of the self-consistency algorithm and the ICM algorithm and
has the fastest convergence. It can be shown that the above NPMLE is consistent. For variance
estimation, a generalized version of the Greenwood formula and a bootstrap approach has been
proposed by Sun (2006).
There is a clear difference between right censoring and interval censoring as the NPMLE
of the survival function based on right-censored data is given by the closed form of the KaplanMeier estimate. The NPMLE of both of these has different asymptotic behavior. Interval
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censoring comes with many difficulties, one of which includes the use of the counting process
technique and the Martingale theory not being applied. As mentioned above, the NPMLE is
consistent for interval-censored data. We get a convergence rate of

5/b

. We can also show that

the limiting distribution is nonnormal, whereas the limiting distribution of the Kaplan-Meier
5/c

estimate is normal with a convergence rate of

.

2.2 Mean of the survival times
In survival analysis, we can find the mean of our survival times by integrating the
survival function. This is true for interval-censored data, but the NPMLE of the survival function
may be harder to integrate. In general, our mean survival time can be found by
μ = e( ) = f. g( )A = − f. A ( ) = − ( )
h

h

h
f.

( )A .

∞
h
+ f. ( ) A =
0

(2.12)

Since the survival function is usually estimated, we can use the NPMLE of the survival

function, E ( ), to find the estimated mean of the survival times, î . This is found by substituting
E ( ) for ( ) in the above integral to get

k

î k = l E ( )A .
.

(2.13)

For censored data, the mean of E ( ) converges to the true mean of ( ). The choice of τ
can be predetermined. Typically, this is chosen to be the maximum right endpoint. That is, an
estimate of the mean is made to be restricted to the interval [0, max]; that is the max observation
time. For interval-censored data, that is the largest right endpoint. Another solution is to estimate
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the mean restricted to some interval [0, τ] where τ is typically chosen to be the longest possible
survival time. The longest possible survival time is different from the maximum observation
time, as the longest possible survival time may not be observed in the study. For either case, the
estimated mean restricted to the interval [0, τ] is given by î k .
2.3 Median of the survival times
The median survival time is defined as the time such that ( )=0.5. In practice, it is

defined as the smallest time in which E ( ) ≤ 0.5. The median has been found to be much more
appropriate for censored survival data than for the mean because it is unaffected by large

observations and censored data. If the E ( )=0.5 over an interval, the median is the midpoint of
that interval. The median can be visualized on a graph of the survival function by drawing a line
at ( ) = 0.5. The intersection of this line and the survival curve is the median. Typically, the

95% confidence interval is used to estimate the median survival time. The p-th quantile of any
random variable x is defined by
Gm = inf( : ( ) ≤ 1 − R).

(2.14)

Gqm = inf : E ( ) ≤ 1 − R .

(2.15)

In other words, for R = 1/2, Gm is the median time to the event. The variable Gm can be
estimated by

2.4 Confidence Interval for the survival function
The confidence interval method for the NPMLE is more complicated for intervalcensored data. It is time consuming because it uses a modified bootstrap which calculates the
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NPMLE for each replication. Many programming tools, such as R, set the default number of
replications at 200. Goodall, Dunn, and Babiker (2004) proposed three ways to find the
confidence interval: the Wald-1 method, the Wald-II method, and the likelihood ratio method.
(I)

The Wald-1 method: Recall the likelihood function for interval-censored data defined in

equation (2.7). The log-likelihood can easily be defined as
4

/

$5

,$5

3 log u3 Q , R, v,

(2.16)

where, as discussed earlier, there is no closed form of the MLE. Wald confidence intervals have
the form

The estimate of E

,

is E

E

,

,

| ( E ( , )).
± xy z{F2

(2.17)

c

= 1 − ∑[$5 R̂[ . We want to write this in a matrix form in order to
,

find the variance. Written as a matrix form, the estimate of E
E

,

•.
= 1 − %,} ~}/(, Z

,

can be rewritten as
(2.18)

The variance of Wald intervals is estimated by
‚ cƒ
{F2(Z) ≈ •−
„ = (…} †…)(5 .
‚R; ‚R9 m,9
(5

(2.19)

Let … be an G7 matrix with elements Q , and † is an G diagonal matrix with elements
A =

1

∑/
,$5 Q , R,

c.

(2.20)
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Then, by equation (2.16) the Wald variance for E ( ) is estimated by
| (Z) = ‡%,} ~}/(5 ˆ(…} †…)(5 ‰
{F2

%,

~/(5

Š

(2.21)

With the variance estimate in (2.19) and the survival estimate in (2.16) the Wald-1 interval is
E ( ) ± xy z{F2
| ‹ E ( )Œ.

(2.22)

c

(II)

The Wald-2 method is a modified version of the Wald-1 method. The Wald-1 method is

based on the “asymptotic theory assuming a fixed number of parameters” (Tao, 2010, p. 16). The
assumption is not assumed in the Wald-2 method. One of the modifications made is
/(5

R/ = 1 − 3 R, ,
,$5

which is eliminated from the model. We assume that R̂, ≠ 0 if

(2.23)
,(5

∈ 8 and

,

∈ O .

• that do not follow these assumptions are said to be zero and are eliminated. Once
Elements of Z
these modifications are made, the Wald-1 method can be used.
(III) The likelihood ratio method refers to the likelihood ratio test. The likelihood ratio statistic
for testing •. :
constraint

,

,

=

.

•) − ƒ(Z
‘)], where Z
‘ is the MLE of Z subject to the
is •( . ) = 2[ƒ(Z

‘=
= 1 − ‡%,} ~}/(5 ˆZ

..

The confidence interval, then, is given by the set of

values:
* . : •( . ) < χcy -.

(2.24)
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SAS and R use these methods to estimate the confidence interval for the survival function
(Tao, 2010). There is an option to specify which method to use; however, the default is the Wald
method.
2.5 Generalized Log-rank test for interval-censored data
Generally, the log-rank test is the summation of the observed times minus the expected

number of deaths or events. It is used to test the null hypothesis that the R + 1 survival functions
corresponding to the treatments are identical. In other words, the test determines if the survival
curves are identical or not. The log-rank test is the most common way to test this null hypothesis
for right-censored data because of its simplicity and ease of interpretation. Statisticians Zhao and
Sun (Sun, 2006) directly generalized the log-rank test to include exact failure times of the
intervals in our data. They also allow this approach to compute the variance and covariance of
the generalized log-rank statistic. One way to use the log-rank test with interval-censored data is
to use the midpoints and perform the log-rank test as for right censoring. Using the midpoint is
practical if your interval is small and narrow. The other option, if the interval is wide and varied,
is to use the intervals and perform a generalized log-rank test. For interval-censored failure time
data for n independent subjects, let 0 < s1 < K < s m be the ordered distinct time points. For each
pair (i, j) define α ij to be the indicator of the event s j ∈ (Li , Ri , = 1 …

]

and j =1,K,m +1. For

convenience, we will assume that E. ( ) is zero for ≥ +/P5. Let δ i = 0 for right-censored data,

δ i =1 otherwise and, ρ ij = I(δ i = 0, Li ≥ d j ) .
The log-rank statistic U is

14
/

”;,M = 3 +,M −
,$5

,M +,
,

,

(2.25)

where
4

A, = 3 •
$5

,

Q , ‡ E. +, − − E. (+, )ˆ
,
E
E
∑/P5
H$5 Q H ‡ . (+H −) − . (+H )ˆ

Q ; ‡ E. (+; −) − E. (+; )ˆ
= 3 3•
+ 3 – ,,
Q H ‡ E. (+H −) − E. (+H )ˆ
/P5 4

4

;$, $5

$5

n

where d jl and n jl are defined as above, with

∑
i=1

is χc with p degrees of freedom.

l

replaced by

∑
i

(2.26)

(2.27)

. The null distribution of ”;,M

2.6 Applications of Basic Quantities
In this section we give several applications of methods described in 2.1-2.4. The
following is an introduction to an example of interval-censored data in a breast cancer study that
we will refer to throughout this paper (Table 1). The data consists of 94 patients who were given
either radiation therapy alone (RT) or radiation therapy plus chemotherapy (RCT). “Patients
were supposed to be seen at the clinic every 4 to 6 months; however, actual visit times vary from
patient to patient and times between visits also vary” (Sun, 2006, p.7). The data contain
information about the time to breast retraction (cosmetic appearance) given the type of therapy
the patients were undergoing. No exact event time was observed, but it is known that the event
occurred in the interval from the last visit in which breast retraction had not occurred and the
visit at which breast retraction was detected. There were 38 patients who did not experience
breast retraction during the study, resulting in right-censored observations. The other
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observations were intervals of time in which the breast retraction was said to have occurred. For
example, the observation (a, b] means that the patient had a clinic visit at time a and no breast
retraction was detected, while at the very next visit at time b, breast retraction was found to be
present already. One objective of the study was to compare the two treatments and their effects
on breast retraction.
Table 1
Interval-Censored Dataset for Time to Cosmetic Deterioration in Breast Cancer
Time to cosmetic deterioration (in months) in breast cancer patients with two treatment
regimens
Radiotherapy only: (0,7]; (0,8]; (0,5]; (4,11]; (5,12]; (5,11]; (6,10]; (7,16]; (7,14]; (11,15];
(11,18]; ≥15; ≥17; (17,25]; (17,25]; ≥18; (19,35]; (18,26]; ≥22; ≥24; ≥24; (25,37]; (26,40];
(27,34]; ≥32; ≥33; ≥34; (36,44]; (36,48]; ≥36; ≥36; (37,44]; ≥37; ≥37; ≥37; ≥38; ≥40; ≥45;
≥46; ≥46; ≥46; ≥46; ≥46; ≥46; ≥46; ≥46.
Radiotherapy and Chemotherapy: (0,22]; (0,5]; (4,9]; (4,8]; (5,8]; (8,12]; (8,21]; (10,35];
(10,17]; (11,13]; ≥11; (11,17]; ≥11; (11,20]; (12,20]; ≥13; (13,39]; ≥13; ≥ 13; (14,17]; (14,19];
(15,22]; (16,24]; (16,20]; (16,24]; (16,60]; (17,27]; (17,23]; (17,26]; (18,25]; (18,24]; (19,32];
≥21; (22,32]; ≥23; (24,31]; (24,30]; (30,34]; (30,36]; ≥31; ≥32; (33,40]; ≥34; ≥34; ≥35;
(35,39]; (44,48]; ≥48.
(a,b]- interval in which deterioration took place
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The NPMLE curve for our breast cancer example is computed using the EM-ICM
algorithm. Figure 1 shows the NPMLE of the survival functions for the radiation therapy
treatment group versus the radiation and chemotherapy treatment group.

Figure 1: Survival Curve Comparison for RT and RCT

The survival curve representing the RCT treatment decreases faster that the RT
chemotherapy curve does, genereally. From this we can conclude that the RT group has longer
times to retraction than the RCT group; patients in the RT treatment seem to have lower risk to
develop breast retraction than those in the RCT treatment group. The median for the NPMLE
would be found by finding the smallest time in which the estimated survival function at time
is less than or equal to 0.5. It is clear from Figure 1 that the median is around 35 months for RT
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and around 20 months for RCT. Table 2 shows the exact estimates of the median and the a 95%
confidence interval for the median.

Table 2
Mean, Median, and Confidence Intervals for the Median
record
Ther= 48

max

start

Event

*rmean *se(rmean) Median LCL

UCL

48

48

35

19.5

1.91

19.5

18.5

30.5

46

46

21

33.5

2.42

39.0

33.5

NA

0
Ther= 46
1
* restricted mean with upper limit = 48.0
Table 2 shows the estimates for the data when therapy is either radiation therapy (therapy
1) or radiation chemotherapy (therapy 0). Note that the median is 19.5 for our data when therapy
is radiation only and 39.0 for radiation and chemotherapy. The confidence interval is estimation
for the median. Notice that these medians are similar to the estimates from our plot from Figure
1. The mean of the survival times for radiation therapy is 24.2 and 33.5 for radiation and
chemotherapy. Notice the asterisk next to the mean in Table 2 denoting that this is a restricted
mean with upper limit 48.0. This is an application of the sample mean where — is chosen to be
48.0. R automatically chooses the largest right endpoint as τ.
Tables 3 and 4 show the survival estimates and confidence intervals for patients with
radiotherapy treatment versus radiotherapy and chemotherapy. Our log-rank test will test
whether our survival distributions are equal or not given the therapy of radiation only or
radiation and chemotherapy.
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Table 3
Survival Estimates and Confidence Intervals for Patients with RCT
Therapy=0
Time

n.risk

n.event

Survival

Std.err

95%CILow 95%CIUpp

4.5

48.0000

2.08

0.9567

0.0294

0.90085

1.000

6.5

45.9224

2.08

0.9134

0.0406

0.83725

0.997

8.5

43.8449

3.32e-15

0.9134

0.0406

0.83725

0.997

11.5

41.8449

3.17e+00

0.8442

0.0529

0.74657

0.955

Table 4
Survival Estimates and Confidence Intervals for Patients with RT
Therapy=1
Time

n.risk

n.event

Survival

std.err

95% CIL

95%CIUp

4.5

46.000

2.13e+00

0.954

0.0310

0.895

1.000

6.5

43.868

1.54e+00

0.920

0.0399

0.845

1.000

7.5

42.332

4.08e+00

0.832

0.0552

0.730

0.947

11.5

38.255

3.25e+00

0.761

0.0629

0.647

0.895

From Table 5, our p-value is 0.007339; therefore, the null hypothesis will be rejected. We
can conclude that there is evidence that our survival distributions are not equal for the two types
of therapies in breast deterioration. There is a statistically significant difference between the two
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groups. In general, from Figure 1, we can see this result illustrated. The RT group has longer
times to retraction than the RCT group.
Table 5
Results for the Generalized Log-Rank Test
Z=-2.6811

p-value=0.007339

n=46

Score statistic =-9.25173

n=48

Score statistic=9.25173

CHAPTER 3: REGRESSION ANALYSIS OF INTERVAL-CENSORED DATA
Regression analysis is common practice in interval-censored data that provides an
assessment of covariate effects on the failure times. In this chapter, we describe methods of
doing regression analysis of interval-censored data.
3.1 Cox Model
One of the ways to perform regression analysis is to use the Cox proportional hazards
model (PH) model. For right-censored data, the partial likelihood approach is a simple and

efficient procedure. This is the preferred method because it is only a function of ˜ and does not
deal with the baseline hazard function. This does not apply to interval-censored data. Usually in
type I data, or current status data, the survival variables cannot be directly measured. Regression
analysis of current status data is done under semi-parametric approaches. The most common
approach is the maximum likelihood estimation. The difference between regression analysis of
right-censored data and interval-censored data is that in interval-censored data one has to
estimate the regression parameters and the cumulative baseline hazard function simultaneously.
This is because the likelihood function is a function of both the finite dimensional regression
parameters and the infinite dimensional cumulative baseline hazard function. Right-censored
data uses the partial likelihood which is free of the baseline hazard function. For current status
interval-censored data, the partial likelihood does not exist, leaving us to work with the full
likelihood.
Sun (2006) proposes the following method for finding the PH model for Case I and Case
II interval-censored data. Suppose there is a survival study with n independent subjects. Let
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represent the observation time. Let ™ be a vector

represent the survival time of interest and let

of covariates. Let β be the regression parameter, and ]. ( ) is the cumulative baseline hazard

function ( . ( ) = exp(− ]. ( ) ), where

data is given in the form ( , • = (

≤

•(

) is the baseline survival function. Current status

), ™# ); = 1, … ,

. It is assumed that ™# , ,

are

independent.
The proportional hazards (PH) model is one of the most commonly used models in
survival analysis. The model has the form
] ( : ™ ) = ]. ( ) exp(™Y ž).

(3.1)

The likelihood is proportional to
8(ž, ]. ) =
For estimation of β and

.,

4
$5

[

.(

)](5(Ÿ` )

¡m¢` ž

<1 − £[S. (C¥ )]

.(

Ÿ`

¦@ .

(3.2)

the maximum likelihood approach is used (equation 3.2). Let 0 <

+5 < ⋯ < +/ denote the ordered distinct time points at
survival functions

¡m™` ž

) that have the form

.(

4
$5

and ¨© the set of all baseline

) = ∏,:9:I_ « (¬-®(y: ) , where ¯ is the vector of

unknown parameters. Using this new notation, the log-likelihood can be rewritten as
4

ƒ(ž, ¯) = 3 °• log[1 −
$5

where 6 ; +, ≤

,`

« ( ¬-®

y: P™± ` ž

,`

. Let †, be the set of indices of subjects for which

be the set of indices of subjects for which
log-likelihood is

] − 3(1 − • )« y:P™ ` ž ²,
±

(3.3)

= +, and • = 1 and O,

= +, , 6 = 1, … , 7. Let Q, = ∑[$5 exp(Q[ ). Then the
,
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ƒ(ž, ¯) = 3 ° 3 log ³
,$5

∈¾:

1 − e(´µ ¬-®
e

¶± · ¸

(´µ ¬-®(¶± · ¸)

¹ − α» 3 e¶Y· ¸ ².
¥¼½µ

(3.4)

To maximize this log-likelihood, the Newton-Raphson algorithm is employed. To use this, the
first two derivatives are needed.
/

‚ƒ(ž, ¯)
±
±
= 3 Q, °3 ™ « ™ # ž ‡¿ Q, , ™ + 1ˆ − 3 ™ « ™ # ž ²,
‚ž
,$5

À¾:

/

ÀÁ:

‚ƒ(ž, ¯)
±
±
= « y: 3 ° 3 ™ « ™ # ž [¿(Q[ , ™ ) + 1] − 3 ™ « ™ # ž ²,
‚Q,
[$,

/

À¾Â

‚ c ƒ(ž, ¯)
= 3 Q, °3 ™ ™′ « ™Y# ž £¿ Q, , ™ + 1
‚ž‚ž′
,$5

ÀÁÂ

À¾:

(3.5)

(3.6)

(3.7)

− Q, « ™ # ž ¿ Q, , ™ ‡¿ Q, , ™ + 1ˆ¦ − 3 ™ ™′ « ™Y# ž ²,
±

/

‚ c ƒ(ž, ¯)
±
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‚QÄ ‚ž
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±
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(3.10)
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¿ Q,, ™

=

« (y: ¬-®

™± ` ž

1 − « (y: ¬-®(™ ` ž)
±

.

(3.11)

Ç 4 and ¯
• 4 be the estimates of β and α and Ç. ( ) be the estimate of the baseline function. The
Let ž
Newton-Raphson algorithm can be a messy computation with data sets that have a large number
of different observation time points (Sun 2006). An alternative is the convex minorant algorithm
which maximizes the likelihood function instead of the log-likelihood function.
Regression analysis for type II interval-censored data seems much simpler since more
information is provided; however, type II data has to deal with two or more variables in
comparison to current status data that only deals with one variable (Sun 2006). A common way
to do regression analysis is to use the proportional hazards model. Suppose we have a survival
study with n independent subjects with survival times (8 , O ], ™# ; = 1, … ,

.

Let ™ represent a p-dimensional vector of covariates from subject i. Also, let ( ; ™) denote the
survival function with covariates Z. The likelihood function, then, is
8 = ∏4$5[ (8 , ™ ) − (O , ™ )].

(3.12)

This section will continue to assume that8 < O . The log-likelihood function is defined as:
ƒ(ž,

.)

4

= 3 log <[ . (8 )]¬-®
$5

™±̀ ž

where β is the vector of regression parameters and
inference about β and

.(

− [ . (O )]¬-®

.(

™±̀ ž

@,

(3.13)

) is the baseline survival function. For

), the maximum likelihood estimator is needed. The following

maximum likelihood is obtained by the work of Sun (2006). The likelihood depends only on

.
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through its time points. Let Q , =

+, ∈ (8 , O ] , 6 = 1, … , 7, = 1, … , . Suppose

∏,[$5 « (¬-®(yÂ) = « ( ∑ÂÈ> ¬-®(yÂ) . The likelihood can be rewritten as
:

(y: ¬-®
ƒ(ž, ¯) = ∑4$5 ƒÉÊ<∑/P5
,$5 Q , [«

™± # ž

− « (y: ¬-®

™± # ž

]@,

. (+, )

=

(3.14)

where Q, = ∑[$. exp(Q[ ) , Q. = −∞, Q/P5 = ∞. To maximize this likelihood, the Newton,

Raphson algorithm can be applied as before, but for general status data, the score functions of α
and β and the observed Fisher information matrix are needed (Sun, 2006). The score functions
are
"

/P5

#$%

,$5

‚ƒ(ž, ¯)
”ž (ž, ¯) =
= 3 ™ Ê (5 3 Q , g ,(5 − g , ,
‚ž

where g , =

"

‚ƒ(ž, ¯)
”y: (ž, ¯) =
= 3 Ê#(% Ë#Ä Ì , ,
‚¯

(3.16)
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M$, (Q M − Q MP5 )

M (+M ; ™

), Q /Pc = 0 and Ê = ∑/P5
,$5 Q , [

(3.15)

+,(5 ; ™ −

+, ; ™ ].

The maximum likelihood estimators of β and α can be determined by solving the score equations
”ž (ž, ¯) = 0, ”y: (ž, ¯) = 0.
Let the observed Fisher information matrix be
(ž, ¯) = Î
where
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To use the Newton-Raphson algorithm further the inverse of the Fisher Information Matrix is
needed. It can be defined by

where

55|c

=
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3.2 Accelerated Failure Time Model
The accelerated failure time model (AFT) provides an alternative to the PH model. The
PH model assumes that the effect of a covariate is to multiply the hazard by some constant,
whereas the AFT model assumes that the effect of a covariate is to accelerate or decelerate the
disease’s life by some constant. The accelerated failure time model is defined as
ƒÉÊ = ™Y ž + •,

(3.21)
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where W is the error term with a distribution unknown. ž is the regression parameter of interest

but it is also unknown. With the accelerated failure time model, inference about ž is wanted. To
get inference, the maximum likelihood is needed. This is according to Sun (1996). Let each
subject studied be observed at time points with data denoted by
<Ú , (” , , • , = (” ,(5 <

Ú is the number of observations with

`
≤ ” , ),$5
,™ ;

Û

= 1, … , @.

(3.22)

independent subjects. Assume that ” 5 < ⋯ < ” Û` and

that ” . = 0. It is also assumed that the ” , ′+ and
estimate the regression parameter ˜. Let

are independent of ™ . The goal is to

be the distribution of • and let Ü be a p-dimensional

vector defined as

Also, let \ , = (

” , (Ü) = log ” , − ™′ Ü.

(3.23)

≤ ” , ) and let ” Ý and ” Á denote the two ” , that are the last observation

time for which \ , = 0 and the first observation time for which \ , = 1. In other words, (” Ý , ” Á ]
is the interval for which

belongs (Sun, 1996). The likelihood function then is
8(˜, ) =

4
$5

[

” Á (˜) −

” Ý (˜) ].

(3.24)

3.3 Applications of Regression Analysis for Interval-Censored Data
In this section, we will give applications to the regression methods mentioned in 3.1-3.2.
The only model that will allow both a PH model and an AFT model is the Weibull regression
models. The following example will be implementing and comparing both models. In a study
posted in the R journal (Gu et al., 2014), dataset is considered from a study on the timing of
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emergence of permanent teeth of children in Belguim. The dataset contains a sample size of
4,430 children conducted between 1996 and 2001. Dental examinations were conducted annually
for a period of six years and tooth emergence was recorded based on visual inspection. In this
example, we will analyze the timing of emergence of only the permanent upper left first
premolars. The timing of tooth emergence is given in the interval from last negative to first
positive dental exam.
The variable ID corresponds to the ID of the child. The variables left and right
correspond to the endpoints to the censoring interval in years. The variable sex refers to the
gender of the child (0=boy, 1=girl). The variable DMF denotes the status of the primary
predecessor of the tooth (0=sound, 1=decayed or missing). As always, right-censored
observations are denoted by setting the right endpoint to infinity. The variable sex is our
explanatory variable and the variable DMF is our stratum indicator. The diagnostics for the PH
model will be found using the variable sex only in Table 6. This variable proves to be significant.
The first test to check in our analysis is if the PH assumption is valid or not. In other words, we
need to test if all the strata’s shape parameters are equal.
Table 6
PH Model Results Before Stratification
Coefficient

Estimate

SE

Z

P-value

Sex

0.331

0.0387

8.55

0
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From Table 7, we see that the p-value of the likelihood ratio statistic is small. The null
hypothesis is rejected, which concludes that the PH assumption is not valid (the hazard functions
corresponding to DMF=0 and DMF=1 are not proportional). It would not be wise to use the PH
model in this example. The estimated regression coefficient for sex is 0.331. The Wald test
shows that the timing of emergence of teeth is significantly different between girls and boys (pvalue=0).
Table 7
Results of the Wald and Likelihood Ratio Test Statistics
Test of proportional hazards for strata (H0: all strata's shape parameters are equal):
Test

Test Statistic

DF

P-value

Wald

44.2

1

2.96e-11

Likelihood Ratio

44.2

2

3.00e-11

Before stratification, it is important to check whether both covariates are significant or
not. Otherwise, stratification may not be necessary. The likelihood ratio test will test the null
hypothesis that neither sex nor DMF are significant in the model.
From Table 8, the likelihood ratio test shows that both variables are significant. The
variable DMF can then be stratified out of the model for more clear results.
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Table 8
Likelihood Ratio Test Results
Loglik(model)= - 5501.781

T = −2(lR − lF)

P-value

Loglik(null)= -5596.986

190.41

1e-16

The proportional hazards assumption can be relaxed in stratified models by allowing the
baseline hazard function to vary across strata defined by a subset of explanatory variables (Gu, et
al., 2014). The results from the PH model can be compared with the results from the AFT model
and a stratified PH model. The AFT model uses the survival package in R, whereas the PH
model uses the straweib package. The results of the stratified PH model are shown in Table 9:
Table 9
Stratified PH Model Results Before Splitting DMF into Subgroups
Coefficient

Estimate

Z

P-value

Intercept

1.84389938

316.81

0.00e+00

Sex

-0.06254599

-8.82

1.13e-18

DMF

-0.06491729

-8.90

5.40e-19

Table 9 shows that the all of the variables are significant. To clarify assumptions made by
the PH and AFT models, the results from the models fitted to each subgroup can be found. The
results from Tables 10 and 11 are from the PH model after splitting DMF into two different
groups.
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Table 10
Stratified PH Model Results After Splitting DMF into Subgroups When DMF Is 0
DMF=0
Coefficient

Estimate

SE

Z

P-value

Sex

0.448

0.0543

8.25

2.22e-16

Table 11
Stratified PH Model Results After Splitting DMF into Subgroups When DMF Is 1
DMF=1
Coefficient

Estimate

SE

Z

P-value

Sex

0.208

0.0554

3.76

0.000169

The AFT model results after splitting the strata are found in Tables 12 and 13.
Table 12
AFT Model Results When DMF Is 0
DMF=0

n=2502

Coefficient

Estimate

SE

Z

P-value

Intercept

1.85029150

0.00665

278.29

0.000000

Sex

-0.074537585

0.00906

-8.23

1.9e-16
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Table 13
AFT Model Results When DMF Is 1
DMF=1

n=1884

Coefficient

Estimate

SE

Z

P-value

Intercept

1.76931556

0.00799

221.51

0.00000

Sex

-0.04303767

0.02265

-3.76

0.00017

The hazard ratios estimates for sex are compared below. The PH model stratifies DMF as
one variable and the column titled “Stratum Subgroup” uses the PH model and stratifies DMF as
two separate variables. Table 14 shows how the PH model without stratification uses a common
hazard ratio of 1.39, whereas after stratification the PH model will use different hazard ratios.
The benefit here is to see the difference between the two levels of DMF. The hazard ratios all
appear to be similar. Each model seems to come to the same conclusion as each of the variables
proves significant. However, as stated before, the AFT model is the best model to use here since
the PH assumption was rejected.
Table 14
Hazard Ratio Comparison
Stratum

AFT

PH

Stratum Subgroup

Dmf=0

1.46

1.39

1.56

Dmf=1

1.35

1.39

1.23

CHAPTER 4: BAYESIAN ANALYSIS OF INTERVAL-CENSORED DATA
In this section we demonstrate the use of Bayesian methods in survival analysis for
interval-censored data.
4.1 Bayesian Proportional Hazard Model
The Cox proportional hazards model is traditionally used throughout survival analysis
with the case of time-independent variables. The baseline hazard function is usually ignored or
simply dropped. However, time-independent regression is not always valid. The Bayesian
proportional hazard model estimates the baseline hazard function in the case that the covariates
are time dependent. “With the recent advances of sampling-based computational tools, it is now
more feasible to consider more general models that incorporate time-varying coefficients.
However, although powerful computational tools enable remarkably complex models to be fitted
with relative ease, there is still the need to make suitably parsimonious model choices” (Sinha, et
al., 1999, p. 585). Bayesian models help to obtain an estimate of the nuisance parameter, the
baseline hazard. There are two models that are commonly compared. The first is a discretized
Bayesian version of the Cox model. The second model is a Bayesian model with time-varying

coefficients. The hazard function is treated as a piecewise constant function with Þ( |x) = Þ[ ß[à
for ∈

[

where ß[ = « áÂ and

[

= (Q[(5 , Q[ ] for Å = 1, … , Ê and ß = Q. < ⋯ < Qâ = ∞

and g is the total number of grid intervals. The Bayesian discretized Cox model will be denoted

as ã. and the Bayesian hazard model with time-varying coefficients will be denoted as ã5 . The
priors assumed by each model are as follows:
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ã. : Þ[ ~ Gamma (å[ , æ[ ), where the Þ[ ′+ are independent for Å = 1, … , Ê and ˜~ ç (˜. , è.c )

where ˜ is a priori independent of all Þ[ , Å = 1, … , Ê.

ã5 : Þ[ has the same prior as ã. ; however, ˜[P5 |˜5 , … , ˜[ ~ç(˜[ , è[c ) for Å = 0, … , Ê where the

˜[ ′+ are priori independent of all Þ[ , Å = 1, … , Ê.

For both models, the hyperparameters are to be known in advance. Since the model ã. is

a discretized version of the Cox model, the prior for the baseline hazard is a discretized gamma
process prior. When the grid intervals are small, this model is similar to the time-continuous
gamma process. “The discretized autocorrelated prior process for the βk’s in ã5 allows the

covariate effect to change over time but also incorporates the prior information that the values of
the coefficient β in adjacent intervals are expected to be somewhat close and the dependence
among the β’s decreases as the interval grows further apart” (Sinha et al, 1999, p. 586). This
assumption applies to situations where the covariate may change over time but will not change
too drastically over time. When choosing the values of the hyperparameters, there are a few
assumptions to make. The hyperparameters should be chosen to represent the prior based on
previous and similar studies, i.e., data from past studies may give the prior mean
variance

å[
éÞc of Þ[ .
[

Let ê =

å[
éÞ and prior
[

QM` , Q;` ˆ ∶ x , = 1, … , } denote the interval-censored data from n patients

where survival time

for the ith patient is known to be within the interval QM` , Q;` ˆ and QM` <

Q;` , which are two of the grid points (Q5 , … , Qâ ). Let x be the covariate value for the ith patient

and ì =

, x : = 1, … ,

be the unobserved complete data set. Denote the set of parameters

34

under either model as í where the dimension depends on which model is being referred to. It can
be assumed that the distribution of

given x is piecewise exponential. Therefore, the likelihood

is given by
8î (í | ì) ∝

â
[$5

=

,∈ÁÂ

where O[ is the set of patients at risk at Q[(5 , ∆,[ = min
failing in

[

à

ðÞ[Â «GR °−Þ[ 3 ß[ : ∆,[ ² ß[
, , Q[

∑:òó à:
Â
ô,

(4.1)

− Q[(5 , †[ is the set of patients

= (Q[(5 , Q[ ], and A[ is the number of patients in †[ . This is a complicated

likelihood which will yield a complicated joint posterior. Sampling-based methods, such as the
Gibbs sampler, are needed in order to sample from the joint posterior. “Gibbs is an iterative
algorithm that alternates between (1) generating the augmented survival times ( ’s) from the
conditional distribution of

,’s given the current values of the parameters (Θ) and observed

censoring intervals (Y) and then (2) generating new values of the parameters from the
conditional distribution of Θ given the augmented data (the set of

’s) (Sinha et al., 1999, p.

586).” For our models, the posterior, [Þ[ | í(öÂ) , ì ], will be obtained by multiplying the

likelihood above by the joint posterior of the hyperparameters and using the terms that involve
Þ[ from the product. From this concept, the posterior [Þ[ | í(öÂ) , ì ] follows a gamma

distribution with parameters (å[ + A[ , æ[ + ∑,ÀÁ: ß[ : ∆,[ ). For ã5 the conditional posterior of
à

˜[ is found by a similar process as above but only up to the corresponding normalizing
constants. The conditional posterior can be given by
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[˜[ |í(áÂ) , ì]
∝ ÷ (˜[ |

c
c
(∑,À¾Â x, ) ø[c ø[(5
+ ˜[(5 ø[c + ˜[P5 ø[(5
c
ø[c + ø[(5

;

à

c
ø[c ø[(5
c )
ø[c + ø[(5

(4.2)

G exp u−Þ[ 3 ß[ : ∆,[ v,
,∈ÁÂ

for Å = 1, … , Ê, where ˜âP5 = 0 and ù(∙ |i, û c ) is the density function for ç(i, û c ). For ã. all
of the ß[ ’s are equal to ß = « á and
[˜ |í(á) , ì]¯ u

ü

ý$%

exp ð−Þ[ 3 « áà: ∆,[ ô exp ð˜ 3 x, ôv
,∈ÁÂ

G ù(˜ |˜. , ø.c ).

The conditional distribution of

for

| í, ì) =

| í, ì] is

`þ
`
Þ[ ß[ ` exp − ∑[(5
M$M` P5 ÞM ßM ∆_ − Þ[ ß[ (

à

(4.3)

for both models is truncated piecewise exponential with

parameters ß[ Þ[ for ƒ P5 ≤ Å ≤ 2 . The density of [
g(

,À¾Â

à

à

`
1 − exp <− ∑M$M
ÞM ßM ` ∆þ_ @
` P5

;

à

− Q[(5 )

,

X [ , ƒ + 1 ≤ Å ≤ 2 , and ∆þ_ = QM − QM(5 . In both of the models, Þ and

(4.4)

can be sampled in

a straightforward manner; however, ˜[ and ˜ are more complicated. The conditional

distributions do not correspond to the standard statistical routines for sampling. The adaptive
rejection algorithm of Gilks and Wild (1992) is needed. This is an algorithm that samples from
any univariate log-concave density to simulate the parameters, since all conditional distributions
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are log-concave (Sinha et al., 1999). The Gibbs sampler can then be used to sample from the
joint posterior.
Upon model selection, there are two proposed ways to choose. The first combines the
predictive variability and the performance of the model (Sinha et al., 1999). Begin with a
quadratic loss function which was proposed by Gelfand and Ghosh (1998):
8

where

; m,

; m

,

• 9

=

; m

−

}

; m

−

+ Å(

• 9

− )} (

• 9

− ),

(4.5)

is an unobserved replication of the vector of uncensored log survival times and

is a vector of the observed log survival times. The vector
able to be close to

; m

• 9

is described as a “compromise.” It is

by the goodness-of-fit property, as well as

• 9

under a good model.

This does not work when the model is too restrictive or too general. The variable Å helps to
decide how much emphasis should be given to the goodness-of-fit of the model versus the
predictive variability. This is usually a predetermined quantity. The idea for a loss function is to

in order to compute 8∗ .

minimize the posterior expectation of the loss function with respect to

Once 8∗ has been computed for both models, the model with the lower 8∗ is chosen. In order

to minimize the posterior expected loss function, e(8 |ê) with respect to , where
restricted to

,• 9

• 9

is

∈ (FM , F; ] for = 1, … , . Thus, the posterior expectation of the loss function

for interval-censored data is
4

8∗ = 3‡var ln
$5

; m

x , ê, ã + •(i −

,• 9 )

c

],

(4.6)
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where i = e(ln

; m |x¥ , ê, ã),

the expected log survival time of a new patient similar to the

observed ith patient with covariate value x and

,• 9

is the point in the (FM , F; ] closest to i ,

i.e.

,• 9

=

i
ln(FM )
ln(F; )

g ln(FM ) ≤ i ≤ F;
g i < ln(FM )
.
g i > ln(F; )

(4.7)

The variable • = [P5. Typically, • is set to equal ½ which corresponds to Å = 1 when we give
[

equal importance to goodness-of-fit and predictive variability. Between the two models, ã. and
ã5 , the model with the lower 8∗ is chosen.

The second method for model selection is using the conditional predictive ordinate
(CPO). The CPO value for the ith observation is defined as
( )= (

∈ (FM , F; ]|x , ê(#) , ã),

where ê(#) is the interval-censored data with the ith patient removed. That is,

(4.8)
( ) is the

posterior predictive probability of the observed data from the ith patient given the modified data
ê(#) under the assumption that the true model is ã. The larger that the value of

( ) is, the

the more that the ith observation supports the model. In comparing the two models, the one with
the larger

( ) is chosen. In 1992, Gelfund proposed an easier equation to find
( ) = Îe ‰

where

(

(5
1
ŠÐ ,
∈ (FM , F; ]|í, x

( ):

(4.9)
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Since this is true, this makes
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exp(− 3 Þ, ß, ` ∆þ, )
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− exp(− 3 Þ, ß, ` ∆þ, ).
,$5

à

(4.10)

( ) much easier to compute. It can be shown that

Û

1
1
3³
¹,
à` þ
à
M
Ú
exp(− ∑,$5 Þ,[ ß,[ ∆, ) − exp(− ∑;,$5 Þ,[ ß,[` ∆þ, )

(4.11)

[$5

where the í[ ’s are K copies of the Gibbs samples from model M. Since the

( ) is available

for all points of for all patients in both models, a plot can be made in order to compare how
many data points support one model versus the other by plotting ln ‰

()

>

( )Š versus

. The model that has more data points supporting it is the better model. In other words, the
model with the higher CPO is a better model.
4.2 Applications of the Bayesian Proportional Hazards Model for Interval-Censored Data
In this section, we will see an example of the Bayesian proportional hazard model
mentioned in section 4.1. A common example used in the Bayesian model comparison is the
breast deterioration example seen earlier. The Gibbs sampler method is implemented for two
models. The first model is a model where the covariate (treatment) is time independent. It is a
Bayesian version of the Cox model. The second model is a model where the covariate is time
dependent. Figure 2 show the difference of the covariates over time.
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Figure 2: Differences of the Covariates over Time

The idea is to see which model fits the data better. Using the package, dynsurv, in R, the
LPMD can be calculated as well as the DIC. The LPML, log-pseudomarginal likelihood is
simply the sum of the log of the CPO’s for each observation in the dataset. Instead of plotting,
these numbers can be compared. The larger the LPML is, the better the model is. Table 15 shows
the estimated LPML and DIC for the two models. Since the LPML is larger and DIC is lower for
model 2, model 2 is a better fit for our data. In other words, the covariate is time dependent.

Table 15
Model Comparison Between a Time-Dependent Model and Time-Independent Model
Model

LPML

DIC

Model 1

-149.1773

294.9305

Model 2

-148.507

290.9727
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4.3 Bayesian Accelerated Failure Time Model
In the frequentist approach, the AFT model estimates the regression coefficients and the
baseline hazard distribution simultaneously but does not estimate the survival function or the
density. This only provides inference about the regression coefficients and not the survival
function, and its density becomes complicated in the case of interval censoring.
Methods for modeling the AFT have been difficult for interval-censored data. Many
approaches have been formed but only a few have been made to handle interval-censored data.
One approach that has been shown to be successful models the prior baseline survival function as
a mixture of Dirichlet processes (MDP) given a standard parametric family of base measures
(Hanson and Johnson, 2004). This model allows for a complete Bayesian solution using MCMC
methods. Prior information for all parameters is able to be incorporated. “Using an MDP allows
a simple semi-parametric generalization of standard parametric models by selection of the
baseline MDP family to be any standard parametric regression deemed reasonable for any
distribution” (Hanson and Johnson, 2004, p. 343). This model only involves a “weight”
parameter. The “analytic intractability” of the Bayesian AFT model has been overcome by
MCMC methods (Hanson and Johnson, 2004, p. 342).
Let

denote the distribution of the baseline survival distribution, G ∈ O m denote the

covariate set, and ( > |G) =
˜ and

( exp(G Y ˜), ∞) denote the survival function. Inference for

are made from an analysis of a random sample of

individuals (Hanson and Johnson,

2004). The baseline distribution is modeled by using a MDP prior centered in a standard
parametric family, the lognormal distribution. The parametric family only holds an
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approximation and the resulting model is robust against misspecification of the baseline
distribution (Hanson and Johnson, 2004). The priors assigned are:
{5 , … , {4 | ~ ,

|Q, i, û c ~† (Q

. ),

.

≡ 8ç(i, û c ),

i|7. , +. ~ç(7. , +. ),

û (c |—5 —c ~ ‹

—5 —c
, Œ,
2 2

˜|˜. , +á ~çm ˜. , +á .

(4.12)
(4.13)
(4.14)
(4.15)
(4.16)

The precision parameter is usually chosen to be Q = 20. Inference about the survival curves
comes from the MCMC output. A sample of the survival curve for a given G is drawn from
(,)

( |G, data)~ « F ‹F(,) ( ), Ë (,) ( )Œ,

(4.17)

for MCMC scan 6 of the posterior distribution with 6 = 1, … , , where
F(,) ( ) = Q (,)

(,)
.

• exp G } ˜ (,) , +∞

+3

4

$5

•J(:) (( exp( G } ˜ (,) ), +∞)„,

(4.18)

`

Ë (,) ( ) = Q (,) + ç − F(,) ( ).

(4.19)

To make posterior inferences from here, several MCMC algorithms are proposed by Hanson and
Johnson (2004). There are two main algorithms which depend on two different Markov chains.
These algorithms will not be discussed further in this paper.
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4.4 Applications of the Bayesian Accelerated Failure Time Model
In this section, we will give an example of the Bayesian accelerated failure time model
for interval-censored data mentioned in section 4.3. Recall the breast deterioration data set
previously introduced. A Bayesian semi-parametric MDP AFT model is considered for this
dataset in order to test whether chemotherapy in addition to radiotherapy has an effect on time to
breast retraction. The covariate of interest is treatment, either radiotherapy and chemotherapy or
only radiotherapy. The precision parameter α was chosen to be equal to 20. The analysis shows
that the posterior mean and 95% HPD for treatment was 0.50 (0.1, 0.8), concluding that
chemotherapy and radiotherapy reduces the time to breast deterioration. The mean and median
time to deterioration is reduced by a factor of 0.4 to 0.8. The posterior median for the
radiotherapy group is 39. Adding chemotherapy reduces this median to 22 months. This
approach is different than the normal AFT because of the fact that it provides inference about the
survival function rather than simply the regression coefficients. Graphing the survival curves
over time (Figure 3) shows no evidence of breast retraction for radiotherapy (plot a) or
radiotherapy and chemotherapy (plot b).
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Figure 3: Survival Curves over Time: (a) RT Group (b) RCT Group

CHAPTER 5: WHICH IS MORE INFORMATIVE?
In this section we explore the possibility of interval censoring (random censoring) being
more informative than random censoring (interval censoring) through Monte Carlo sampling.
A dataset generated in R has four covariates. Two of the four covariates are binary
variables, and the other two variables are generated from a normal distribution. All of the values
of these covariates are positive with a total of 200 subjects. Using these covariates, intervalcensored data can be generated as well as random-censored data by creating an accelerated
failure time model and fitting the survival times to the model.
5.1 Simulating Random-Censored Data Given Covariates
Suppose an accelerated failure time model is given as
= 2 + 3G5 + 4Gc + 5Gb + 6G + 2 ,

(5.1)

where the covariates are known and ~ç(0,1). Random-censored data can be generated by
comparing this model to another model where the error is uniformly distributed i.e.:
∗

= 2 + 3G5 + 4Gc + 5Gb + 6G + 2

c

,

where the covariates are known and ~” gÉ27(0,1). Let x = min( ,

said to be randomly censored (right) if x =

uncensored if x =

∗

(5.2)
∗

). An observation is

for any given patient. Likewise, an observation is

for any given patient. After fitting the survival times, x , to an accelerated

failure time model in R, it is clear that the coefficients produced are similar to the ones defined in
the model above. Table 16 summarizes the model output. As seen from Table 16, all of the
covariates prove significant with small standard errors.
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Table 16
AFT Model Results After Simulation of Random-Censored Data
Covariate

Estimate

Error

Z

P-value

Intercept

2.78

0.306

9.1

8.94e-20

G5

3.02

0.196

15.4

1.99e-53

4.05

0.206

19.3

2.27e-83

4.91

0.351

14.0

2.26e-44

5.99

0.160

37.5

8.24e-308

Gc
Gb
G

Suppose we want to find the MSE of the coefficient of the covariate G5 . This model can

be run 1000 times and the estimate of the coefficient of G5 can be recorded each time and

compared to the true coefficient of G5 , which is equal to 3. After 1000 trials, the MSE is found to

be equal to 0.02130184. This may change with a different sample size. A comparison of MSE to
the change in sample size can be seen in Table 17.
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Table 17
Comparison of MSE to n and Censoring %
Sample Size

Censoring %

MSE

50

30

0.1102627

100

34

0.0445193

200

36

0.02130184

From Table 17 we can see that the MSE decreases as the sample size increases. Also, the
censoring percentage seems to increase as the sample size increases and the MSE decreases as
the censoring percentage increases.
5.2 Simulating Interval-Censored Data Given Covariates
For simulating interval-censored data, the AFT model (equation 5.1) used in generating
random-censored data will be used again. That is, let
= 2 + 3G5 + 4Gc + 5Gb + 6G + 2 ,

where

~ç(0,1). In order to simulate interval-censored data,

Given the AFT model, the

, ƒ , and 2 need to be simulated.

’s can easily be simulated. However, ƒ and 2 are more difficult.
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Simulation for interval-censored data comes with certain assumptions. We assume that

there are exactly Å known inspection times. Not every patient will attend each inspection time.

Each subject attends the Åth inspection time with probability ¿, where ¿ is usually fixed and
known:
¿ = 0 + Ë6«Ì 7 ++«+ Fƒƒ Ég ℎ« +R«Ì É
¿ = 1 + Ë6«Ì F « A+ Fƒƒ Ég ℎ« +R«Ì É
0 < ¿ < 1 + Ë6«Ì F « A+ +É7« +R«Ì É
F A 7 ++«+ É ℎ«2+

7«+
7«+
7«+

All of the patients will attend the first inspection time R5. The inspection times are known

(usually in weeks or months). Depending on the value of ¿, a subject will have actual inspection

times F where F ∈ . The following algorithm, created by Kaveh Kiani and Jayanthi Arasan, is
used to simulate the interval-censored data for the first subject:
c ~”

gÉ27(0,1).

(i)

Generate

(ii)

Define the indicator function:
=

(iii)
(iv)

1, g + Ë6«Ì F « A+ Rc (
0, g + Ë6«Ì 7 ++«+ Rc (

Repeat steps (i) and (ii) for R, where 6 = 3,4, … ,

c

c

≤ ¿)
.
> ¿)

Create a vector of attendance for all the Å members of . Consequently this vector
will direct us to a set of actual inspection times. For example, vector

(1,0,0,1,0,1,0,0,1) shows that the patient attended …5 = (F55 , F5c , F5b , F5 ) =

(R5 , R , R , R! ).
(v)

Select the largest member of the vector which is less than
member of the vector which is more than

as ƒ and the smallest

as 2 . It is clear that

< F55
° 5 > F5/
5 = F5,
5

(vi)

ÉË+«2 F É + ƒ«g Ì« +É2«A → (ƒ5 , 25 ) = (0, F55 )
ÉË+«2 F É + 2 Êℎ Ì« +É2«A → (ƒ5 , 25 ) = (F5/ , ∞)
ÉË+«2 F É + «GFÌ + 2 Fƒ 7« → ƒ5 = 25 = F5, .
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Repeat steps (i) to (v) to obtain intervals for other subjects.

After programming this algorithm in R and fitting an AFT model to it, the following results are
gathered in Table 18. Table 18 shows the first few observations for the newly generated left and
right endpoints of the censored data.

Table 18
Newly Generated Left and Right Endpoints for Interval-Censored Data
Left

Right

16

20

10

12

17

18

10

13

20

22

8

9

Table 19 shows the fitted model with coefficients, p-values, and error values. From Table 19, the
covariates appear to all be significant. The MSE can be computed in a similar manner to the
random-censoring simulation. After 1000 trials the estimate of the coefficient of

G5 can be compared to the true estimate of the coefficient of G5 , which is 3. The MSE after 1000

trials is 0.1280145. The censoring percentage, the attendance probability, and the sample size
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have an effect on the MSE. The censoring percentage can be changed for interval censoring by

changing the value of Å, the number of total inspection times. Tables 20, 21, and 22 compare the

MSE to difference values of ¿, sample sizes, and values of Å.

Table 19
AFT Model After Simulation of Interval-Censored Data
Covariate

Estimate

S.E.

Z

P-value

Intercept

2.27

0.325

6.97

3.15e-12

G5

2.84

0.196

14.46

2.17e-47

3.78

0.219

17.29

5.52e-67

5.04

0.342

14.71

5.36e-49

5.60

0.160

35.05

3.36e-269

Gc
Gb
G
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Table 20
MSE Comparison for Different Values of q and k When n=50
n=50
Q

1

0.67

0.5

K

Censoring %

MSE

Rand %

Int %

30

2

98

0.003575195

20

12

88

4.701244e-06

10

84

16

0.0001554432

30

0

100

0.3556879

20

16

84

0.0355205

10

78

22

0.1370531

30

0

100

2.150587

20

22

78

0.1484606

10

90

10

13.35225

50

Table 21
MSE Comparison for Different Values of q and k When n=100
n=100
Q

1

0.67

0.5

K

Censoring %

Interval-

Rand %

Int %

censoring MSE

30

0

100

0.4081439

20

11

89

0.08779438

10

86

14

1.108674

30

0

100

0.1556303

20

16

84

0.1186733

10

86

14

1.124731

30

0

100

0.05709272

20

19

81

0.06724351

10

87

13

0.2972376
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Table 22
MSE Comparison for Different Values of q and k When n=200
n=200
Q

1

0.67

0.5

K

Censoring %

Interval-

Rand %

Int %

censoring MSE

30

0.05

99.5

0.3235479

20

13

87

0.1446086

10

86.5

13.5

0.1230973

30

0.05

99.5

0.02185829

20

17

83

0.0337283

10

87

13

0.7005745

30

0

100

0.1249201

20

20.5

79.5

0.03812271

10

84.5

15.5

1.761146

From Tables 20, 21, and 22, it is clear that the MSE tends to be larger when the data is
more randomly censored than interval censored. The censoring percent of interval-censored data
increases with the increasing values of Å. The MSE tends to be smallest when the percentage of
interval censoring is larger than the random censoring. This suggests that interval censoring is
better overall than random censoring. When compared to the MSEs from using random
censoring only, the MSE was lower for a larger sample size in random censoring than interval
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censoring. In conclusion, interval censoring may be better for smaller samples, and random
censoring may be better for larger samples.
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CONCLUSION
Interval-censored data can be generally more complicated to work with. Randomcensored data works with different methods in comparison; however, interval-censored data can
be helpful in studies when it is difficult to constantly watch a subject. Research is constantly
being done to simplify these methods and for other types of interval-censored data, such as
multivariate data analysis, multivariate Bayesian analysis, and doubly censored data. Doubly
censored data is another type of interval-censored data when the subject experiences two
different events, one followed by the other. A common example is the event of interest of time to
an infection and the second event is the time to getting the disease. This type of intervalcensored data requires much more research before analyzing.
The same methods used for random censoring can be applied to interval censoring.
Although much research has been done for regression analysis of interval-censored data, nothing
is simpler than the partial likelihood method for random censoring.
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Basic Survival Quantities:
library(survival)
km<-survfit(Surv(icboth$left,icboth$right,type="interval2")~icboth$ther)
plot(km,xlab="Months on study",ylab="Estimated survival function",lty=1:2, mark.time=F)
summary(km)
icout<-ictest(Surv(icboth$left,icboth$right,type="interval2")~icboth$trt)

Cox PH model and AFT model:
library(straweib)
data(tooth24)
head(tooth24)
fittooth<-icweib(L=left,R=right,data=tooth24,strata=dmf,covariates=~sex)
plot(fittooth,Z=1, trange=c(1,7), xlab="Time(years)", ylab="Survival function",
main="Estimated survival function for girls")
plot(fittooth,Z=0, trange=c(1,7), xlab="Time(years)", ylab="Survival function",
main="Estimated survival function for girls")
library(survival)
tooth24.survreg<-tooth24
tooth24.survreg$right<-with(tooth24,ifelse(is.finite(right),right,NA))
fit1<survreg(Surv(left,right,type="interval2")~sex+strata(dmf)+factor(dmf),data=tooth24.survreg)
fit10<-icweib(L=left,R=right,data=tooth24[tooth24$dmf==0, ],covariates=~sex)
fit11<-icweib(L=left,R=right,data=tooth24[tooth24$dmf==1, ],covariates=~sex)
fit20<survreg(Surv(left,right,type="interval2")~sex,data=tooth24.survreg[tooth24.survreg$dmf==0, ])
fit21<-survreg(Surv(left,right,type="interval2")~sex,
data=tooth24.survreg[tooth24.survreg$dmf==1, ])
HR.straweib<-exp(fittooth$coef[1,1])
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HR.survreg<-exp(-fit1$coefficients['sex']/fit1$scale)
HR.subgroup<-exp(c(fit10$coef[1,1],fit11$coef[1,1]))
HRatio(fit, times = 1:7, NumStra = 0, NumZ = 0, DemStra = 1, DemZ = 0)
fit0 <- icweib(L = left, R = right, data = tooth24)

Bayesian Cox PH model:
library(dynsurv)
data(bcos)
data<-bcos
grid<-grids
formula <- Surv(left, right, type="interval2") ~ trt
fit40 <- bayesCox(formula, data, grid, out="tiCox3.txt",
model="TimeIndep",
base.prior=list(type="Gamma", shape=0.1, rate=0.1),
coef.prior=list(type="Normal", mean=0, sd=1),
gibbs=list(iter=100, burn=20, thin=1, verbose=TRUE, nReport=5))
plotCoef(coef(fit0))
fit1100 <- bayesCox(formula, data, grid, out="tvCox3.txt",
model="TimeVarying",
base.prior=list(type="Gamma", shape=0.1, rate=0.1),
coef.prior=list(type="AR1", sd=1),
gibbs=list(iter=100, burn=20, thin=1, verbose=TRUE, nReport=5))
plotCoef(coef(fit1))
plotCoef(rbind(coef(fit0),coef(fit1), coef(fit2)

Bayesian AFT model:

))
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library(DPpackage)
data(deterioration) attach(deterioration)
y <- cbind(left,right) # MCMC parameters
mcmc <- list(nburn = 20000, nsave = 10000, nskip = 20, ndisplay = 1000, tune = 0.25)
# Prior information prior <- list(alpha = 10, beta0 = rep(0,1), Sbeta0 = diag(100,1), m0 = 0, s0 =
1, tau1 = 0.01, tau2 = 0.01)
# Fitting the model fit <- DPsurvint(y ~ trt, prior = prior, mcmc = mcmc, state = NULL, status =
TRUE)
xnew <- matrix(c(0,1), nrow=2, ncol=1)
grid <- seq(0.01,70,1)
pred <- predict(fit, xnew=xnew, grid=grid)
plot(pred, all=FALSE, band=TRUE)

Simulation:
library(survival)
mydata<-intcox.example
x1<-mydata$x.1
x2<-mydata$x.2
x3<-abs(mydata$x.3)
x4<-abs(mydata$x.4)

get.betaRC<-function(k)
{
z<-c()
e<-rnorm(200,0,1)
e2<-runif(200,0,1)
y=2+3*x1+4*x2+5*x3+6*x4+2*e
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y2=2+3*x1+4*x2+5*x3+6*x4+2*e2

for(i in 1:200)
{
z[i]=min(y[i],y2[i])
}

deltaC<-c()
for(i in 1:200)
{
if (z[i]==y2[i])
{
deltaC[i]=1
}
if (z[i]==y[i])
{
deltaC[i]=0
}
}
RC<-data.frame(matrix(cbind(z,deltaC)))
ModelRandom<-survreg(Surv(z,deltaC)~x1+x2+x3+x4,data=RC,dist="gaussian",scale=1)
betaRC<-coef(summary(ModelRandom))["x1"]
return(betaRC)
}

repp<-replicate(1000,get.betaRC())
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betaone<-c()
diff<-c()
diffsq<-c()

for (k in 1:1000)
{
betaone[k]<-3
}
for (k in 1:1000)
{
diff[k]=repp[k]-betaone[k]
}
for(k in 1:1000)
{
diffsq[k]=diff[k]^2
}

MSERC<-sum(diffsq)/1000
SERC<-MSERC^.5
MSERC
SERC
e<-c()
y<-c()
e<-rnorm(200,0,1)
y<-2+3*x1+4*x2+5*x3+6*x4+2*e
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get.beta1<-function(m)
{
u22<-matrix(ncol=30,nrow=200)
u22<-matrix(c(runif(3000,0,1)),ncol=30,nrow=200)
kk<-matrix(c(0),ncol=30,nrow=200)
kk[,1]=1
q=0.5
p=c()
for (i in 1:30)
{
p[i]=i-1
}

for(i in 2:30)
{
for(j in 1:200)
{
if (u22[j,i]<=q)
{
kk[j,i]=1
}
}
}

for(i in 1:30)
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{
for(j in 1:200)
{
if(kk[j,i]==1)
{
kk[j,i]=p[i]
}
}
}

lefty<-c()
lefty[1:200]<-c(0)
right[1:200]<-c(0)
deltaleft<-c()
deltaright<-c()
min<-c()
kknew=matrix(nrow=200,ncol=30)

for( j in 1:200)
{
kknew[j,]=sort(kk[j,], decreasing=FALSE)
}

kknew2=kknew
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for(j in 1:200)
{
for( i in 1:30)
{
if(kknew[j,i]==0)
{
kknew2[j,i]=1000
}
}
}

for(j in 1:200)
{
max[j]<-max(kknew[j,])
min[j]<-min(kknew2[j,])
}

for(i in 1:30)
{
for(j in 1:200)
{
if (y[j]>=max[j])
{
lefty[j]=max[j]
right[j]=100
deltaright[j]=1
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deltaleft[j]=0
}
if (y[j]<=min[j])
{
lefty[j]=0
right[j]=min[j]
deltaleft[j]=1
deltaright[j]=0
}
}
}

kknew[is.na(kknew)]<-0

for ( i in 1:30)
{
for(j in 1:200)
{
if (y[j] >= kknew[j,i] & y[j]<= kknew[j,i+1])
{
lefty[j]=kknew[j,i]
right[j]=kknew[j,i+1]
deltaleft[j]=0
deltaright[j]=0
}
}
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}

lr<-matrix(cbind(lefty,right),ncol=2,nrow=200)
colnames(lr)<-c("left","right")
dataframenew<-data.frame(lr)
aft1<-survreg(Surv(left,right,type="interval2")~x1+x2+x3+x4,data=dataframenew,
dist='gaussian',scale=1)
beta1<-coef(summary(aft1))["x1"]
return(beta1)
}

rep<-replicate(1000,get.beta1())

betaoneIC<-c()
diffIC<-c()
diffsqIC<-c()

for (k in 1:1000)
{
betaoneIC[k]<-3
}
for (k in 1:1000)
{
diffIC[k]=rep[k]-betaoneIC[k]
}
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for(k in 1:1000)
{
diffsqIC[k]=diffIC[k]^2
}
MSEIC<-sum(diffsqIC)/1000
SEIC<-sqrt(MSEIC)
MSEIC
SEIC

